Particle.news

Jan Wächter Has End‑Stage Adrenal Cancer

Specialist clinicians at University Hospital Heidelberg are reviewing treatment options that will decide whether further systemic therapy or primarily supportive care is appropriate.

Overview

  • Wächter was first diagnosed in 2025 with adrenocortical carcinoma and had a large tumor removed in a multi‑hour operation followed by an oral tablet therapy that produced a strong response.
  • Doctors later detected metastases in his liver, and his disease has been described as end‑stage, prompting his transfer for care to Uniklinik Heidelberg where treatment options are now under review.
  • Adrenocortical carcinoma is very rare in Germany, with roughly 100 new cases a year, and limited research means long‑term prognosis and clear treatment pathways are often uncertain.
  • Wächter has spoken publicly about his outlook, saying he is not ready to die and describing the illness as a chance to expand his horizons.
  • The diagnosis has forced him to cancel freelance social‑media contracts, live on sick pay, and try to earn money by uploading music online as clinicians and family weigh next steps.